Vascular endothelial growth factor (VEGF) signalling through VEGF receptor-2 (VEGFR-2) plays a central role in angiogenesis, and blockade of VEGF/VEGFR-2 signalling is an important antiangiogenic strategy for cancer therapy. Here, KDR is linked to cancer.